Management of Difficult Cases of Autoimmune Hepatitis (Q33619600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Management of Difficult Cases of Autoimmune Hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Veronica M Loy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Kiyoko Oshima

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Samer Gawrieh

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

Current gastroenterology reports

5 March 2020

language of work or name

English

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance

5 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Investigation Gone Viral: Application of the Social Mediasphere in Research.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Prediction of short- and long-term outcome in patients with autoimmune hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Review article: the management of autoimmune hepatitis beyond consensus guidelines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Drug choices in autoimmune hepatitis: Part A – steroids

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Outcomes of pregnancy in women with autoimmune hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Diagnosis and management of autoimmune hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

The impact of ethnicity on the natural history of autoimmune hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Management and outcome of pregnancy in autoimmune hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

A gender gap in autoimmunity.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Use of a xanthine oxidase inhibitor in autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Rapamycin successfully treats post-transplant autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Pregnancy in autoimmune hepatitis: outcome and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Recurrent autoimmune hepatitis after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Risk factors for recurrence of autoimmune hepatitis after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

A case study: refractory recurrent autoimmune hepatitis following liver transplantation in two male patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-015-0484-7

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5410647

Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease

30 October 2018

1 reference

12 December 2020

Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience

1 reference

12 December 2020

Use of sirolimus in the treatment of refractory autoimmune hepatitis

1 reference

12 December 2020

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

12 December 2020

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

1 reference

12 December 2020

EASL Clinical Practice Guidelines: Autoimmune hepatitis

1 reference

12 December 2020

Features and consequences of untreated type 1 autoimmune hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis

1 reference

12 December 2020

Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients

1 reference

12 December 2020

Liver transplantation for autoimmune hepatitis: a long-term pathologic study

1 reference

12 December 2020

Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure

1 reference

12 December 2020

[Liver, blood proteins and nutritive protein]

1 reference

12 December 2020

Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects

1 reference

12 December 2020

10.1007/S11894-015-0484-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780632%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

26780632

1 reference